Table 1 List of Covid-19 relevant aggregates and module sets
From: A modular framework for the development of targeted Covid-19 blood transcript profiling panels
Module aggregate | Module Set | Modules | Functional annotations |
|---|---|---|---|
A1 | A1/S1 | M14.42, M15.38, M12.6, M13.27, | T cells |
A1/S2 | M14.23, M15.87, M14.5, M14.49, M12.1, M14.20 | Gene transcription | |
A1/S3 | M12.8, M15.29, M14.58, M15.51, M14.64, M16.78, M14.75, M15.82, M14.80 | B cells | |
A2 | A2/S1 | M13.21, M9.1 | Cytotoxic lymphocytes |
A2/S2 | M14.13, M14.72, M13.13, M13.14, M14.45, M13.10, M15.91 | TBD | |
A4 | A4/S1 | M16.69, M16.72, M16.50, M16.77 | Antigen presentation, |
A5 | A5/S1 | M16.95, M16.36 | B cells |
A5/S2 | M16.57, M16.18, M16.65, M16.111, M16.99 | B cells | |
A7 | A7/S1 | M15.61 | Monocytes |
A8 | A8/S1 | M16.30 | Complement |
A8/S2 | M16.106 | TBD | |
A10 | A10/S1 | M15.102 | Prostanoids |
A26 | A26/S1 | M12.2 | Monocytes |
A27 | A27/S1 | M13.32, M12.15, M16.92, M15.110, M16.60 | Antibody producing cells |
A28 | A28/S1 | M15.127, M8.3 | Interferon response |
A28/S2 | M15.64 | Interferon response | |
A28/S3 | M15.86, M10.1, M13.17 | Interferon response | |
A31 | A31/S1 | M14.81, M16.64 | Platelet/Prostaglandin |
A31/S2 | M14.48, M14.38, M15.58 | Monocytes | |
A33 | A33/S1 | M15.104, M14.82, M14.24, M15.108 | Cytokines/chemokines, Inflammation |
A33/S2 | M14.19, M14.76, M14.50, M14.26, M16.101, M16.100, M16.80 | Inflammation | |
A34 | A34/S1 | M14.39, M14.59, M10.3, M16.109, M8.2 | Platelets, prostanoids |
A35 | A35/S1 | M14.65, M14.28, M15.81, M16.79, M13.3, M14.7, | Monocytes, neutrophils |
A35/S2 | M15.26, M12.10, M13.22, M15.109, M15.78, M13.16, | Neutrophils, inflammation | |
A36 | A36/S1 | M16.34, M16.82, M15.97, M14.51, M15.118, M16.88 | Gene transcription |
A37 | A37/S1 | M9.2, M14.53, M11.3, M12.11, M15.100 M15.74, M13.26, M13.30, M15.53, | Erythroid cells |
A38 | A38/S1 | M10.4 | Neutrophil activation |
A38/S2 | M16.96, M12.9, M14.68 | Erythroid cells |